Moneycontrol
HomeNewsBusinessIndiGo welcomes Akasa Air, launches seventh Bengaluru-Kochi flight hours after new airline announces routes

IndiGo welcomes Akasa Air, launches seventh Bengaluru-Kochi flight hours after new airline announces routes

IndiGo the largest airline in India in terms of market share has a history of chocking out the competition in the Indian aviation industry through its aggressive route offerings and frequencies on those routes.

July 24, 2022 / 15:03 IST
Story continues below Advertisement

InterGlobe Aviation-run IndiGo airlines on July 22 launched its seventh frequency flight on the Bengaluru - Kochi route, hours after Akasa Air announced that it plans to operate five flights between the two cities from August 13.

IndiGo, the largest airline in India in terms of market share, has a history of choking out the competition through its aggressive route offerings and frequencies on those routes.

Story continues below Advertisement

ALSO READ: Akasa reveals routes, fares, inflight offerings—are they enough to take on IndiGo?

"Back when AirAsia India and Vistara had started their operations in India in 2014 as well, IndiGo started adding capacity to counter the competition for newcomers," said Lokesh Sharma, a senior defense and aviation analyst.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show